Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)

Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R) Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Proves Administration of PhosphoLean™ (N-Oleyl-Phosphatidylethanolamine and EGCG) Improves Diet Compliance, Insulin Resistance, Depressive Symptoms and Binge Eating Associated With Dieting A study published by Dr. Mariangela Rondanelli, University of Pavia, Italy, in the July 2008 issue of the prestigious British Journal of Nutrition, proves that PhosphoLean(TM) NOPE + EGCG can significantly improve a person’s ability to stay on their stressful diet and successfully lose weight. Study Proves Administration of PhosphoLean™ (N-Oleyl-Phosphatidylethanolamine and EGCG) Improves Diet Compliance, Insulin Resistance, Depressive Symptoms and Binge Eating Associated With Dieting A study published by Dr. Mariangela Rondanelli, University of Pavia, Italy, in the July 2008 issue of the prestigious British Journal of Nutrition, proves that PhosphoLean(TM) NOPE + EGCG can significantly improve a person’s ability to stay on their stressful diet and successfully lose weight. Study Proves Administration of PhosphoLean™ (N-Oleyl-Phosphatidylethanolamine and EGCG) Improves Diet Compliance, Insulin Resistance, Depressive Symptoms and Binge Eating Associated With Dieting A study published by Dr. Mariangela Rondanelli, University of Pavia, Italy, in the July 2008 issue of the prestigious British Journal of Nutrition, proves that PhosphoLean(TM) NOPE + EGCG can significantly improve a person’s ability to stay on their stressful diet and successfully lose weight. Study Proves Administration of PhosphoLean™ (N-Oleyl-Phosphatidylethanolamine and EGCG) Improves Diet Compliance, Insulin Resistance, Depressive Symptoms and Binge Eating Associated With Dieting A study published by Dr. Mariangela Rondanelli, University of Pavia, Italy, in the July 2008 issue of the prestigious British Journal of Nutrition, proves that PhosphoLean(TM) NOPE + EGCG can significantly improve a person’s ability to stay on their stressful diet and successfully lose weight. Study Proves Administration of PhosphoLean™ (N-Oleyl-Phosphatidylethanolamine and EGCG) Improves Diet Compliance, Insulin Resistance, Depressive Symptoms and Binge Eating Associated With Dieting A study published by Dr. Mariangela Rondanelli, University of Pavia, Italy, in the July 2008 issue of the prestigious British Journal of Nutrition, proves that PhosphoLean(TM) NOPE + EGCG can significantly improve a person’s ability to stay on their stressful diet and successfully lose weight. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Study Proves Beneficial Effects of Phosphatidylserine (PS) on Stress Management A study published today in the Journal of the International Society of Sports Nutrition indicates that the consumption of a phosphatidylserine (PS) can help to effectively manage exercise induced stress and promote healthy free testosterone levels. Study Proves Beneficial Effects of Phosphatidylserine (PS) on Stress Management A study published today in the Journal of the International Society of Sports Nutrition indicates that the consumption of a phosphatidylserine (PS) can help to effectively manage exercise induced stress and promote healthy free testosterone levels. Study Proves Beneficial Effects of Phosphatidylserine (PS) on Stress Management A study published today in the Journal of the International Society of Sports Nutrition indicates that the consumption of a phosphatidylserine (PS) can help to effectively manage exercise induced stress and promote healthy free testosterone levels. Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar. Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar. Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar. Senomyx Announces Initiation of Development Activities for New Sucrose Enhancer Senomyx, Inc. (SNMX) has announced that it has initiated development activities for a new sucrose enhancer, S6973, where taste tests show the product enabling the reduction of up to 50% of the sucrose present in product prototypes while maintaining the sweet taste of natural sugar. Experts continue to cite Bifantis as promising probiotic treatment for Irritable Bowel Syndrome Two new review articles that cover therapeutic approaches to irritable bowel syndrome (IBS) in the July issue of Nutrition in Clinical Practice, cite growing evidence that probiotics, and specifically Bifidobacterium infantis 35624 (Bifantis®), are effective in helping manage IBS. Experts continue to cite Bifantis as promising probiotic treatment for Irritable Bowel Syndrome Two new review articles that cover therapeutic approaches to irritable bowel syndrome (IBS) in the July issue of Nutrition in Clinical Practice, cite growing evidence that probiotics, and specifically Bifidobacterium infantis 35624 (Bifantis®), are effective in helping manage IBS. Prestigious Confirmation of Low-Carb Diet Poised to Revitalize Weight Loss Nutraceutical Industry A study published in the July 17th, 2008 edition of the New England Journal of Medicine1 showed clearly that a low-carb diet helped people lose more weight than a Mediterranean-style diet and the common low-fat diet. In addition, researchers discovered that a low-carb diet also helped improve healthy cholesterol ratios. Prestigious Confirmation of Low-Carb Diet Poised to Revitalize Weight Loss Nutraceutical Industry A study published in the July 17th, 2008 edition of the New England Journal of Medicine1 showed clearly that a low-carb diet helped people lose more weight than a Mediterranean-style diet and the common low-fat diet. In addition, researchers discovered that a low-carb diet also helped improve healthy cholesterol ratios. Prestigious Confirmation of Low-Carb Diet Poised to Revitalize Weight Loss Nutraceutical Industry A study published in the July 17th, 2008 edition of the New England Journal of Medicine1 showed clearly that a low-carb diet helped people lose more weight than a Mediterranean-style diet and the common low-fat diet. In addition, researchers discovered that a low-carb diet also helped improve healthy cholesterol ratios. New study suggests Carnipure(TM) supplementation improves bone mineral density A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats. New study suggests Carnipure(TM) supplementation improves bone mineral density A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats. New study suggests Carnipure(TM) supplementation improves bone mineral density A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats. New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers. New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers. New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers. 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily. 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily. 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev. Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev. Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev. Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev. Pharmanex Study Correlates Skin Carotenoids to Overall Antioxidant Health Scientists from Nu Skin Enterprises, Inc. (NUS) , presented results and consistency of findings from two large studies at the 15th International Symposium on Carotenoids in Okinawa, Japan, indicating that skin carotenoid levels measured with the Pharmanex(R) BioPhotonic Scanner correlate with, and are a good indication of, the body's overall antioxidant defense system. Pharmanex Study Correlates Skin Carotenoids to Overall Antioxidant Health Scientists from Nu Skin Enterprises, Inc. (NUS) , presented results and consistency of findings from two large studies at the 15th International Symposium on Carotenoids in Okinawa, Japan, indicating that skin carotenoid levels measured with the Pharmanex(R) BioPhotonic Scanner correlate with, and are a good indication of, the body's overall antioxidant defense system. InterMed Discovery achieves Proof-of-Principle for IMD-026260 InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate. InterMed Discovery achieves Proof-of-Principle for IMD-026260 InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate. InterMed Discovery achieves Proof-of-Principle for IMD-026260 InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate. Potassium Increases May Lower Blood Pressure A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults. Potassium Increases May Lower Blood Pressure A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults. Potassium Increases May Lower Blood Pressure A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults. Potassium Increases May Lower Blood Pressure A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults. Potassium Increases May Lower Blood Pressure A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing. Vitamin D for Babies May Prevent Diabetes Later in Life A study published in the Archives of Disease in Childhood revealed that vitamin D supplementation in babies may help to prevent Type 1 Diabetes later on in life. Vitamin D for Babies May Prevent Diabetes Later in Life A study published in the Archives of Disease in Childhood revealed that vitamin D supplementation in babies may help to prevent Type 1 Diabetes later on in life. Vitamin D for Babies May Prevent Diabetes Later in Life A study published in the Archives of Disease in Childhood revealed that vitamin D supplementation in babies may help to prevent Type 1 Diabetes later on in life. Vitamin D for Babies May Prevent Diabetes Later in Life A study published in the Archives of Disease in Childhood revealed that vitamin D supplementation in babies may help to prevent Type 1 Diabetes later on in life. Vitamin D for Babies May Prevent Diabetes Later in Life A study published in the Archives of Disease in Childhood revealed that vitamin D supplementation in babies may help to prevent Type 1 Diabetes later on in life. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice. Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC. Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	EDMONTON, ALBERTA--(Marketwire - Aug. 4, 2008) - CV Technologies Inc. (TSX:CVQ) - Pediatrics - the official journal of the American Academy of Pediatrics and a prestigious medical journal - has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children. It's the first time COLD-fX has been studied for pediatric use. The results are contained in the August, 2008 issue. The researchers report in Pediatrics that they could find only seven other studies of natural health products (NHPs) for children up to the year 2007. The lack of studies of this nature was described as "especially concerning" given that "current estimates suggest that 41% to 45% of children in Canada and the United States use NHPs". The researchers say that further study is now merited to measure the effectiveness of COLD-fX in treating children with colds and flu. The Company anticipates launching large-scale clinical studies within the next fiscal year testing for efficacy to further support the use of COLD-fX for treating colds and flu in children. Seventy-five children between the ages of three and 12 were recruited in Edmonton for the study which was conducted in the winter of 2005-2006. Of the children recruited, 46 developed an upper respiratory tract infection (URTI). Within 48 hours of onset, they were randomly assigned to receive acute three-day treatments with either a placebo or COLD-fX (two weight based dosage levels). Both dosage regimens were well tolerated with no significant adverse reactions reported in the study. The President, CEO and Chief Scientific Officer of CV Technologies, Jacqueline Shan PhD, DSc, says, "We are honored to have the trial results on COLD-fX reported in this prestigious journal. Children suffer from colds and flu substantially more often than adults. We hope this trial will be viewed as timely and beneficial research in an area where there is a demonstrated need for safe and effective products to treat colds and flu in children." The results of this trial came at a time when Health Canada and the FDA (Food and Drug Administration) in the U.S. are reviewing the dosage and efficacy of roughly 700 children's cough and cold remedies currently for sale in both countries, particularly for children under the age of six. A study by the Centers for Disease Control and Prevention (CDC) says over 7,000 children under 12 are treated each year in U.S. hospital emergency rooms for adverse drug reactions from cough and cold medications. The COLD-fX study is part of a Company program designed to consider new products and product extensions. The positive safety results were previously announced by the Company in February of 2008 and have been presented at two major scientific conferences in the UK and Canada. About the Trial: The trial was approved by Health Canada and the University of Alberta Ethics Committee. About Pediatrics. Pediatrics is the official journal of the American Academy of Pediatrics and is recognized as the leading peer reviewed pediatrics publication in the world. It is printed in four languages with a circulation of nearly 80,000 copies. It began publishing in 1948. ABOUT CV TECHNOLOGIES INC. CV Technologies, founded in 1992, strives to transform people's lives to be healthier and happier by focusing on prevention and recovery through the use of evidence-based naturally-derived health products. The Company's lead product COLD-fX® strengthens the immune system and is widely used as a leading over the counter remedy (OTC) for helping to prevent and relieve cold and flu infections. COLD-fX continues to rank as the number one selling cold and flu remedy in Canada (ACNielsen's MarketTrack Drug Service for Cold Remedies, Natural Supplements & Vitamins Categories for the 52 week period ending March 15, 2008. Forward Looking Information This news release contains certain forward-looking information within the meaning of applicable securities laws. The forward-looking information included in this document does not guarantee future performance and should not be unduly relied upon. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information including, without limitation: those comments predicting the timing and/or initiation of clinical trials, particularly those related to pediatric clinical trials, clinical trial results, and associated regulatory clearances, financing and acceptance of COLD-fX® in the marketplace. The use of any of the words "aims", "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "would", "project", "could", "should", "believe", "plans", "targets", "intends" and similar expressions are intended to identify forward-looking information. The Company believes that the expectations and assumptions reflected in the forward-looking information contained herein are reasonable but no assurance can be given that these expectations and assumptions are correct and that the results, performance or achievements expressed in, or implied by, forward-looking information within this disclosure will occur, or if they do, that any benefits may be derived from them. All forward-looking information is expressly qualified in its entirety by this cautionary statement. The Company assumes no duty to update or revise forward looking information, except as may be required pursuant to applicable laws. The Company is a 12g3-2(b) SEC registrant.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software